Announced Tue, 2 Jun · 16:41 IST

Annual Report for the Financial Year 2025-2026.

Investor Communications View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.7%1-day move
₹12.80
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-5.7-6.3-1.6-6.5-15.4-13.8-15.2
Up moveDown movePending
AI summary

Global Longlife Hospital and Research Limited has submitted its Annual Report for FY 2025-2026 along with the notice for its 15th AGM to be held on June 25, 2026 via video conferencing. The company's financials show deeply stressed operations with gross turnover of just Rs. 0.52 lakhs and a net loss of Rs. 171.95 lakhs, though net worth remains healthy at Rs. 2,374.93 lakhs. Management is seeking shareholder approval for a major strategic pivot: changing the company name to Kanzi/Asahi/Siddhaa Enterprise Limited and altering the object clause to enter food commodities, agriculture produce, textiles, apparel, bullion trading, and commodity exchange businesses. Additionally, the AGM will consider re-appointing Mr. Dhruv Jani as Managing Director (salary up to Rs. 36 lakhs p.a.) and Mr. Manasvi Thapar as Independent Director for a second five-year term, and regularising the appointment of Mr. Hiren Mandaliya as Independent Director.

Likely market impact

This filing signals a near-complete business transformation — the healthcare-focused company is exiting its core line of business to become a diversified trading and commodities entity. For shareholders, this means existing business operations are being wound down and the company's future earnings profile will depend on the success of new ventures, which carry execution and pivot risk. The near-zero revenue and widening losses underscore the urgency behind the strategic shift.